An exploratory analysis of the cost-effectiveness of insulin glargine 300 units/mL versus insulin glargine 100 units/mL over a lifetime horizon using the BRAVO diabetes model
Shao H, Shi L, Fonseca V, et al.
Diabet Med. 2024;e15303.
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Shao H, Shi L, Fonseca V, et al.
Diabet Med. 2024;e15303.
Leggi
He D, Gao B, Wang J, et al.
Diabetes Care. 2024;dc232364.
Leggi
Limonte CP, Gao X, Bebu I, et al.
Diabetes Care. 2024;dc232196.
Leggi
Ahmadi MN, Blodgett JM, Atkin AJ, et al.
Diabetologia. Pub. online 13 Mar 2024.
Leggi
Peng M, He S, Wang J, et al.
Diabetes Obes Metab. Pub. online 15 Mar 2024.
Leggi
Helmink MAG, Hageman SHJ, Eliasson B, et al.
Diabetes Obes Metab. Pub. online 8 Mar 2024.
Leggi
Ghusn W, Fansa S, Anazco D, et al.
Diabetes Obes Metab. Pub. online 12 Mar 2024.
Leggi
Brown DM, Boyer DS, Do DV, et al.
Lancet. 2024;S0140-6736(23)02577-1.
Leggi
Jain AB, Reichert SM, Amadid H, et al.
Diabetes Obes Metab. Pub. online 11 Mar 2024.
Leggi
Zhao H, Wu Y, Xie Y, et al.
Diabetes Obes Metab. Pub. online 11 Mar 2024.
Leggi